Insider transactions

Kirsten Flowers

CIK 1797209 · CCO & Chief Strategy Officer · last filed 2026-06-05

Kirsten Flowers is a CCO & Chief Strategy Officer who has filed 16 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for PMVP, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$9.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $198.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$198.2K
Companies
3
Total Filings
16
Lifetime Open-Market Net
-$9.9K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

KURA price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
C/O KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400
SAN DIEGO, CA 92130
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PMVP Director — $1.13 — $0 6 2026-06-05
Comera Life Sciences Holdings, Inc. (CMRAW) Delisted Director 22,199 $0.02 $428 $16.6K 6 2023-11-14
KURA CCO & Chief Strategy Officer 20,605 $9.62 $198.2K -$26.5K 4 2023-01-31

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-05 PMVP Grant (A) — $0 EDGAR
2025-06-09 PMVP Grant (A) — $0 EDGAR
2024-06-10 PMVP Grant (A) — $0 EDGAR
2023-11-14 Comera Life Sciences Holdings, Inc. (CMRAW) Delisted Grant (A) — $0 EDGAR
2023-09-01 Comera Life Sciences Holdings, Inc. (CMRAW) Delisted Grant (A) — $0 EDGAR
2023-06-12 PMVP Grant (A) — $0 EDGAR
2023-05-16 Comera Life Sciences Holdings, Inc. (CMRAW) Delisted Grant (A) — $0 EDGAR
2023-02-16 Comera Life Sciences Holdings, Inc. (CMRAW) Delisted Grant (A) — $0 EDGAR
2023-02-14 Comera Life Sciences Holdings, Inc. (CMRAW) Delisted Buy (P) +13,513 $16.6K EDGAR
2023-01-31 KURA Sell (S) −1,906 -$26.5K EDGAR
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.